Story · Medicine & Biotech

FDA Expedited Investigational New Drug (IND) Pilot Program

1 outlet · first reported by FDA Drug Safety / Drugs feed 7d ago

Coverage, in order

  1. 7d ago
    FDA Drug Safety / Drugs feed indie
    FDA Expedited Investigational New Drug (IND) Pilot Program

    The FDA Expedited IND Pilot Program is an initiative under HHS Operation TrialBlazer designed to evaluate new approaches for accelerating first-in-human (FIH) clinical trials in the United States while maintaining FDA's rigorous standards for participant safety and scientific oversight.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.